Figure 1. Study Group Selection Flow Diagram .

T2D indicates type 2 diabetes.

^aThe combined total of patients is not necessarily a sum of the individuals from each of the groups because individuals could be prescribed both glucagon-like peptide 1 receptor agonists (GLP-1RAs) and insulins or metformin during the study period.

^bThe combined total of patients is not necessarily a sum of the individuals from each of the groups because individuals could be prescribed both insulins and metformin during the study period.